New incident report
Incident Report Number: 2013-6343
Registrant Reference Number: 1-35216941
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: FLORIDA
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-79
Product Name: UltraGuard Flea/Tick Powder for Dogs
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: advantage
Dust
Yes
Unknown
Site: Animal / Usage sur un animal domestique
No
Animal's Owner
Cat / Chat
Unknown
1
Male
8
Unknown
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
Yes
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
1-35216941 - The reporter, a pet owner, indicated that her cat was exposed to a dog insecticidal powder containing the active ingredient tetrachlorvinphos and to a non-registrant spot-on flea and tick product called advantage with unknown active ingredients. The reporter applied the registrant product to all the cats and dogs in her house three days prior to initial contact with the registrant to treat a significant flea infestation. The non-registrant spot-on product was applied to her 8 year old, male cat two weeks prior to initial contact with the registrant but per the reporter it was not effective at controlling the fleas. Within 24 hours of applying the registrant powder the reporters male, 8-year-old cat was lethargic, anorexic and having difficulty breathing. At the time of the initial call the cat was at the veterinary clinic where blood work showed that the cat was anemic and had some white blood cell problems. The veterinarian had not yet come to a definitive diagnosis but she was currently treating the cat with an unknown steroid and an unknown antibiotic. The reporter was advised that per package labeling this product is only meant to be used on dogs. The reporter was further advised that the described blood abnormalities are not consistent with exposure to the product and continued veterinary care was recommended to determine an underlying cause and appropriate treatment. Blood cholinesterase testing was also recommended to assist in reaching a diagnosis. On follow-up call, two days later, the reporter indicated that she brought the cat home from the veterinarian and was in the process of bathing the cat when it had a seizure and died. No further information is available.
Death